A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer

MLA

Ting Deng, et al. “A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer.” Pharmaceutics, vol. 15, no. 3, Mar. 2023, p. 944. EBSCOhost, https://doi.org/10.3390/pharmaceutics15030944.

APA

Ting Deng, Yibo Hou, Gaoyang Lin, Chunyan Feng, Kewei Liu, Wenke Chen, Wei Wei, Laiqiang Huang, & Xiaoyong Dai. (2023). A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer. Pharmaceutics, 15(3), 944. https://doi.org/10.3390/pharmaceutics15030944

Chicago

Ting Deng, Yibo Hou, Gaoyang Lin, Chunyan Feng, Kewei Liu, Wenke Chen, Wei Wei, Laiqiang Huang, and Xiaoyong Dai. 2023. “A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer.” Pharmaceutics 15 (3): 944. doi:10.3390/pharmaceutics15030944.